Arkolith/Insider Trading/BMRN/Form 4

Davis George Eric

EVP, Chief Legal OfficerBIOMARIN PHARMACEUTICAL INC (BMRN) · full profile →Form 4 · filed Feb 26, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.6M
Net Open-Market Flow
-$1.6M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 26, 2026Sell(S)26K$61.36$1.6M72K
Feb 25, 2026Grant(A)2K—$099K
Feb 25, 2026Grant(A)7K—$096K
Feb 25, 2026Grant(A)6K—$089K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-012533) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML